On page 1456 the Acknowledgment section details were incomplete. The corrected Acknowledgment section is: ISTA Pharmaceuticals Inc provided ketorolac tromethamine ophthalmic solution 0.5% and bromfenac sodium ophthalmic solution 0.09% free of charge for this study and monetary compensation to the subjects to encourage participation. Dalton and Associates provided medical editing expertise.
. 2011 Oct 31;5:1557. doi: 10.2147/OPTH.S27293
Corrigendum
Issue date 2011; Collection date 2011.
© 2011 Wang et al, publisher and licensee Dove Medical Press Ltd
This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
PMCID: PMC3218164 PMID: 22125401
This corrects the article "Evaluation of analgesic efficacy of bromfenac sodium ophthalmic solution 0.09% versus ketorolac tromethamine ophthalmic solution 0.5% following LASEK or Epi-LASIK" on page 1451.